Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model

Am J Obstet Gynecol. 1998 Sep;179(3 Pt 1):758-61. doi: 10.1016/s0002-9378(98)70078-x.

Abstract

Objective: The object was to determine the placental transfer of ritonavir alone and in combination with zidovudine.

Study design: Twelve placental perfusion studies were performed at trough (1-2 microg/mL) and peak (approximately 20 microg/mL) combinations of ritonavir and zidovudine. Accumulation of ritonavir was determined.

Results: Transfer of ritonavir at trough concentrations was undetectable (<0.025 microg/mL). The clearance index of ritonavir at peak concentration was 0.085 +/- 0.05 and was unaffected by zidovudine. The fetal concentration of ritonavir was 0.0758 +/- 0.22 microg/mL at a maternal concentration of approximately 20 microg/mL and 25.5 +/- 6.9 microg/mL at a concentration of 100 microg/mL. There was no tissue accumulation of ritonavir either alone or with zidovudine.

Conclusion: The clearance index of ritonavir at therapeutic levels was extremely low, with little accumulation in the fetal compartment and no accumulation in placental tissue. Zidovudine does not significantly affect the transfer or accumulation of ritonavir.

MeSH terms

  • Anti-HIV Agents / pharmacokinetics*
  • Drug Combinations
  • Female
  • HIV Protease Inhibitors / pharmacokinetics*
  • Humans
  • Maternal-Fetal Exchange
  • Osmolar Concentration
  • Perfusion
  • Placenta / metabolism*
  • Pregnancy
  • Reproducibility of Results
  • Ritonavir / pharmacokinetics*
  • Zidovudine / pharmacokinetics*

Substances

  • Anti-HIV Agents
  • Drug Combinations
  • HIV Protease Inhibitors
  • Zidovudine
  • Ritonavir